A non-invasive test being studied in clinical trials at Columbia and 11 other medical centers may soon offer a simpler, more comfortable way to diagnose endometrial (uterine) cancer.

Early-stage, strategic investments help researchers test bold ideas, creating momentum and new directions in cancer research.

A new study reveals how disrupted DNA navigation leads to impaired red blood cell development in myelodysplastic syndrome

HICCC researchers will present updates across key cancer research topics at this year's American Association for Cancer Research annual meeting.

Oncology dietician Sabrina Oliver reflects on the new “inverted” food pyramid and how people can interpret the guidelines through a cancer-prevention lens.

Columbia researchers have discovered the natural mechanism behind a type of cell death called ferroptosis - solving a longstanding puzzle in cell biology.

In honor of Black History Month, we spoke with Dr. Tyler about why she thinks disparities research should be a priority in sarcoma care.

GLP-1 weight-loss medications have changed how doctors treat obesity- here’s what we know about their impact on cancer.

We spoke with Rob Wechsler-Reya, PhD, about a novel functional precision medicine approach that he developed, which is being tested in a national clinical trial now opening at Columbia.

The Herbert Irving Comprehensive Cancer Center earned renewed Comprehensive Cancer Center designation from the National Cancer Institute for 2025–2030, with $27 million in funding to strengthen cancer...

Engineered inhalable exosomes deliver a bispecific T cell activator to pembrolizumab-resistant metastatic melanoma.

Liquid biopsies have the potential to transform cancer care. We asked Dr. Chin Hur how these tests fit into the future of personalized cancer screening, now that one has FDA approval.

A new study forecasts a substantial rise in uterine cancer cases and deaths over the next three decades, with a disproportionate impact on Black women.

Mariam El-Ashmawy, MD, PhD, shares what you need to know about tattoos and skin cancer—and how to protect your skin for the long run.

We answer 10 of the most common—and often misunderstood—questions about how cancer clinical trials work, who they’re for, and why they matter.

NewYork-Presbyterian neurosurgeon Dr. Brian Gill describes the SONOBIRD trial, which tests a new implantable ultrasound device that may improve drug delivery to the brain to treat glioblastoma.

Nicole Lamanna, MD, discusses pirtobrutinib decision-making in the relapsed/refractory CLL setting and ongoing earlier-line research with the agent.

YouTube video by Herbert Irving Comprehensive Cancer Center at Columbia

Columbia researchers are uncovering potential new therapies to counter the changing identities of cancer cells.